Campaign designed to increase periodontal disease awareness, treatment
OraPharma, Inc., a pharmaceutical company specializing in the dental market, is launching a periodontal disease patient education and awareness campaign designed to encourage patients to inquire about gum disease and periodontal health.
OraPharma, Inc., a pharmaceutical company specializing in the dental market, is launching a periodontal disease patient education and awareness campaign designed to encourage patients to inquire about gum disease and periodontal health.
The campaign also encourages patients to choose the comprehensive treatment of periodontal disease if it is diagnosed.
The campaign also encourages patients to choose the comprehensive treatment of periodontal disease if it is diagnosed.
The campaign is based on recently conducted dental consumer market research* that came to four main conclusions:
The campaign is based on recently conducted dental consumer market research* that came to four main conclusions:
1. Most consumers surveyed did not know that periodontal disease is a chronic bacterial infection
1. Most consumers surveyed did not know that periodontal disease is a chronic bacterial infection
2. Most of these consumers have little awareness and knowledge of periodontal disease, its treatment, or its long-term implications.
2. Most of these consumers have little awareness and knowledge of periodontal disease, its treatment, or its long-term implications.
3. Very few consumers were aware that periodontal disease may potentially be associated with chronic diseases, although the exact relationship has yet to be determined.
3. Very few consumers were aware that periodontal disease may potentially be associated with chronic diseases, although the exact relationship has yet to be determined.
4. After learning that periodontal disease is a chronic bacterial infection, 74 percent of those surveyed would choose immediate treatment with scaling and root planing with an adjunctive treatment such as a locally applied antibiotic even if it were not covered by their insurance.
4. After learning that periodontal disease is a chronic bacterial infection, 74 percent of those surveyed would choose immediate treatment with scaling and root planing with an adjunctive treatment such as a locally applied antibiotic even if it were not covered by their insurance.
The research also showed that when patients were educated, they would be more willing to follow their dental practitioners' recommendations for treatment and understood the need for adjunct antibiotic therapies to help reduce the bacteria left behind by scaling and root planing.
The research also showed that when patients were educated, they would be more willing to follow their dental practitioners' recommendations for treatment and understood the need for adjunct antibiotic therapies to help reduce the bacteria left behind by scaling and root planing.
According to Michael Cavanaugh, OraPharma's Executive Director of Marketing, "The survey validates what we've always suspected � the primary reason patients delay treatment of periodontal disease is due to a lack of understanding of the true nature of periodontal disease � while it may be painless and go unnoticed by the patient for years - it's a chronic infection that needs to be treated like any other infection in the body."
According to Michael Cavanaugh, OraPharma's Executive Director of Marketing, "The survey validates what we've always suspected � the primary reason patients delay treatment of periodontal disease is due to a lack of understanding of the true nature of periodontal disease � while it may be painless and go unnoticed by the patient for years - it's a chronic infection that needs to be treated like any other infection in the body."
The OraPharma Periodontal Disease Patient Education Campaign consists of several colorful in-office patient education tools including brochures, patient self-exam cards and other related pieces that are available to dental professionals through the OraPharma account management and customer service teams.
The OraPharma Periodontal Disease Patient Education Campaign consists of several colorful in-office patient education tools including brochures, patient self-exam cards and other related pieces that are available to dental professionals through the OraPharma account management and customer service teams.
These unbranded tools provide patients with detailed information regarding periodontal disease, risk factors and treatment options embedded within market research-validated visuals designed to catch and hold the attention of dental patients and direct them to talk to their dental professional for more information.
These unbranded tools provide patients with detailed information regarding periodontal disease, risk factors and treatment options embedded within market research-validated visuals designed to catch and hold the attention of dental patients and direct them to talk to their dental professional for more information.
The in-office pieces are designed for the busy dental professional to quickly educate and inform a patient about their periodontal infection while also guiding them through the treatment options.
The in-office pieces are designed for the busy dental professional to quickly educate and inform a patient about their periodontal infection while also guiding them through the treatment options.
According to Dr. Sheri B. Doniger, a dental industry author and practicing dentist in Lincolnwood, Ill., "OraPharma's new education materials make it easy for dental professionals to explain to their patients that periodontal disease is a chronic oral infection. This campaign will be extremely useful in increasing patients' knowledge of periodontal disease, making the dental professionals' job of diagnosing and treating this prevalent disease much easier."
According to Dr. Sheri B. Doniger, a dental industry author and practicing dentist in Lincolnwood, Ill., "OraPharma's new education materials make it easy for dental professionals to explain to their patients that periodontal disease is a chronic oral infection. This campaign will be extremely useful in increasing patients' knowledge of periodontal disease, making the dental professionals' job of diagnosing and treating this prevalent disease much easier."
